中文

百洋医药 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-29
ItemAmountY/Y
Revenue¥1.78B-3.1%
Gross profit¥0.70B
Operating income¥0.19B
Net income¥0.16B+41.8%
Gross margin39.5%Net margin 8.7%
Revenue Q/Q-5.1%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥1.08B60.5%
R&D¥0.01B0.3%
SG&A¥0.46B25.7%
Tax & other¥0.04B2.2%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

雷尔伟漱玉平民申菱环境宁波色母密封科技英诺激光海泰科奕帆传动霍普股份读客文化浩通科技华蓝集团

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies